Market Trends of Prepacked Chromatography Columns Industry
This section covers the major market trends shaping the Prepacked Chromatography Columns Market according to our research experts:
Affinity Segment Expected to Witness Growth
Affinity chromatography is the technique that allows the purification of proteins based on biological functions rather than individual physical or chemical properties. Affinity chromatography is the preferred approach for the primary capture and purification of different proteins, nucleic acids, viral vectors, and exosomes. Increasing demand for therapeutic protein, wide usage of affinity membrane chromatography in the biopharmaceutical industry, and increasing innovation in affinity resins are propelling the segment's growth. For instance, in February 2022, Repligen Corporation launched AVIPure AAV affinity resins which are anticipated to have a significant application in gene therapy manufacturing. The newly launched resin is available in OPUS prepacked columns. Moreover, the growing biotechnological sector is supplementing the demand for prepacked chromatography columns. For instance, according to the data published by Invest India in 2022, the Indian biotech sector grew by 14% and crossed USD 80.1 billion in 2022.
Furthermore, new product launches and strategic activities by major players in the market are positively affecting the growth of the studied market. For instance, in February 2021, Repligen and Navigo Proteins launched an affinity resin, also available in off-the-shelf, prepacked, and pre-qualified OPUS Columns configuration, for the purification of COVID-19 vaccines. This significantly strengthened its product portfolio. Thus, due to product launches and technological advancements, the studied segment is expected to grow considerably over the forecast period.
North America Expected to Dominate the Market
North America is expected to dominate the market owing to factors such as high R&D spending, well-established research organizations, and the easy availability of prepacked chromatography columns. According to the Pharmaceutical Research and Manufacturers of America, PhRMA member companies' R&D investments reached a record high of USD 102.3 billion in 2021. In addition, the presence of a high number of pharmaceutical and biopharmaceutical companies in the United States is among the key factors contributing to the growth of the studied market in North America.
A high number of partnerships and collaborations and a high concentration of market players in the United States are some of the factors driving the growth of the prepacked chromatography columns market. In March 2020, Astrea Bioseparations came into agreement with Thermo Fisher Scientific for prepacked bioseparation columns. This non-exclusive supply agreement with Thermo Fisher Scientific to manufacture pre-packed EvolveD columns that will include CaptureSelect and POROS chromatography resins of Thermo Fisher Scientific. This collaboration is anticipated to significantly enhance their product offering. Such continuous developments in the region are anticipated to drive the growth of the studied market in the North America region.
